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An attempt was made to isolate secretory component 
from the molecule secretory immunoglobulin A. Two methods 
were used, each with colostrum as the source of secretory 
component. In the first method, colostrum was centrifuged, 
and the supernatant was chromatographed on a Sephadex G-200 
column. Half of the eluates were concentrated by negative 
pressure dialysis, and half of the eluates were chromato-
graphed on a carboxymethyl-50 cation exchange column. All 
eluates collected were subjected to immunoelectrophoresis. 
In the second method the colostrum was clarified, and the 
proteins were precipitated by the addition of ammonium 
sulfate. The eluates were chromatographed on a DEAE cellu-
lose column using a stepwise elution of three sodium 
phosphate buffers. Further chromatography included a 
CM-50 cation exchange column and identlfication of the 
proteins by the method of Ouchterlony using rabbit anti-
serum against secretory IgA. 
Free or unattached secretory component was found in 
the second elution peaks from the Sephadex G-200 gel fil-
tration column and from the first fraction of colostral 
whey eluted using O.OlM sodium phosphate buffer, at pH 7.6. 
Secretory component was highly contaminated with 
lactoferr1n and was not obtained in a pure state. 
Failure to obtain spurring between second peak 
eluates and anti S-IgA could be the result of differences 
in quarternary structure between the tetrameric free form 
and the IgA bound form. 
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INTRODUCTION 
Immunoglobulin A is the predominant immunoglobulin 
in the secretions of the exocrine glands. IgA present in 
external secretions such as colostrum and secretions of the 
urinary tract differs structurally from that present in 
serum. Not only does exocrine IgA or secretory IgA 
(S-Iga) have a higher sedimentation constant (lIS as com-
pared to 78 in serum IgA), but it has a greater molecular 
weight and contains additional antigenic determinants not 
present in the serum IgA. The extra antigenic determinants 
are due to an additional glycoprotein moeity called secre-
tory component (SC). This glycoprotein can either exist 
as an unbound moeity called "free" SC, or as an integral 
part of the IgA molecule (1,2,3,4,5,6,7,8,9). 
There has been much research on the production sites 
of SC and IgA. Evidence supporting different production 
sites for IgA and SC have been reported. First, SC is 
found in, and thought to be synthesized by, epithelial 
cells in various parts of the body (10,11). Second, 
agammaglobulinemic persons have been reported as producing 
free secretory component, and third, an excess of SC above 
IgA levels has been shown. Thus, the IgA is believed to be 
produced in local plasma cells, whereas the SC glycoprotein 
molecule is believed formed in the epithelial cells of the 
exocrtne glands (12,13). 
The exact function of SC has not been determined. 
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Tomasi has postulated that the component serves as a 
"transport piece" from the site of production in the lamina 
propria, through the epithelial cells of the surface of the 
mucous membrane (14). The biological function of SC bind-
ing to IgA molecules is thought to be facilitation of the 
transport of S-IgA across the mucous membranes into secre-
tions (3), and/or protection of the IgA from proteolytic 
degradation in the digestive tract (2,15). 
Tomasi has reported that since S-IgA bathes the 
mucous membranes of the body it serves as the first line 
of defense (14). Thus, a study of the effectiveness of 
the S-IgA portion of the secretory immune system against 
urinary tract infections may offer some insight into its 
etiology and pathogenesis. 
In order to quantify the levels of S~IgA in urine 
it is necessary to have monospecific antisera. Monospeci-
fic antisera is required since antisera for S-IgA reacts 
in an identical manner with both the serum IgA, S-IgA, 
and free or fragmented alpha chains in the urine. The 
purpose of this project is to perfect the isolation of SC 
to produce the antisera for this glycoprotein. This 
antisera will then be used in conjunction with antisera 
to S-Iga to identify the whole molecule. 
METHODS AND MATERIALS 
Method One 
Colostrum was collected during the antepartum per-
iod. The whole colostrum was refrigerated after collection 
and processed in the following manner. The lipids and cell 
fragments were removed by centrifugation at 26,000 Xg for 
30 minutes. Lipids and debris were discarded, and the 
supe~natant was divided into 2 ml aliquots and frozen. 
Colostral proteins were subjected to Sephadex G-200 
gel filtration, carried out in a 40 x 2.5 column, using 
upward flow elution. The flow rate was maintained between 
16-18 ml!hr using the elution buffer, O.OlM Tris pH 8 
with 0.14M sodium chloride. The temperature was maintained 
at 4C. Approximately half of the second peak eluates were 
concentrated by negative pressure dialysis for immunoelec-
trophoretic studies. The second peak eluates not concen-
trated from the Sephadex G-200 column were subjected to a 
carboxymethyl-50 Sephadex cation exchange column. CM 
Sephadex cationic exchange was carried out in a 40 x 2.5 em 
column, using upward flow elution at a rate of 20-22 ml/hr. 
The elution buffer used was O.5M potassium monobasic with 
0.05M sodium phosphate dibasic pH 6 and 7, at 4C. Eluates 
were concentrated by negative pressure dialysis. 
The optical density of the eluates was measured at 
280nm in a Beckman DB-G grading spectrophotometer and the 
data plotted as optical density versus fraction number. 
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Immunoelectrophoresis using special Difco noble agar 
at a concentration of 1.5% was carried out according to 
Wood's procedure (16). 
Method Two 
Colostrum was prepared as described in the first 
method except the casein was extracted by a pH adjustment 
to 4.0 with the addition of concentrated hydrochloric acid 
followed by centrifugation at 30,000 Xg for 30 minutes. 
The supernatant, now termed clarified colostral whey, was 
saved and the pH readjusted to 7.4 with 0.5N sodium 
hydroxide. The proteins were then precipitated with a 
solution of ammonium sulfate at 50% saturation, at pH 6.5. 
The precipitate was then dialyzed against O.OlM sodium 
phosphate at pH 7.4, which was the starting buffer for DEAE 
column chromatography. 
The prepared colostral whey was chromatographed on a 
DEAE cellulose column using a stepwise elution of three 
sodium phosphate buffers: (1) O.OlM, pH 7.6; (2) 0.1M, 
pH 6.4; and (3) 0.3M, pH 4.8. The fraction eluted from 
0.1M sodium phosphate buffer, pH 6.4 was further chromato-
graphed on a CM-ce11u1ose column (2 x 2.5 cm) using a 
linear gradient between O.005M and 0.5M sodium acetate 
buffer, pH 5.0. 
The fraction containing IgA was identified through 
double diffusion, using the method of Ouchterlony, with a 
rabbit antiserum against S-IgA. 
RESULTS 
Method One 
Sephadex G-200 gel filtration chromatography of 
clarified human milk produced an elution pattern marked 
by three or four peaks (Figure 1). The first elution peak 
of human milk contained S-IgA and at least one component 
with a larger molecular weight than S-IgA (16). The second 
elution peak contained free SC, lactoferrin, and several 
serum proteins including albumin (12). The remaining two 
peaks contained protein material; however, the identifica-
tion of these proteins was not done for the purposes of 
this study. 
In Figure 2 the upper wells contained clarified 
colostral whey, and the lower wells contained the eluates 
of the second peak. The troughs contained anti S-IgA. The 
eyebrow arcs seen in the slides exhibited the same electro-
phoretic mobility as the secretory component identified by 
Tomasi and Bienenstock (2). 
In Figure 3 the upper wells contained first peak 
eluates, the lower right wells contained anti S-IgA, and 
the lower left wells contained second peak eluates. After 
72 hours the slide showed a precipitation l~ne between 
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Figure 1 Gel filtration chromatography. The first elution peak contains 
S-IgA. The second elution peak contains free SC, lactoferrin, and sev-
eral serum proteins. The remaining two peaks were not identified. 
-J 
( 
Fig. 2.--P~eclpltation reaction of clari-
fied colostral whey and second peak eluat es. The 
upper wells contained clarified colostra l whey , 
and the lower wells contained the eluates of the 
second peak. The troughs contained anti S ~IgA. 
/ 
, o 
Fi g . 3.-~Oucht erlony method of doubl e dif-
fusion. The upper wells contained first peak 
eluates, the l ower r i ght well s contained anti 
S-IgA, and the lower left c ontained second peak 
eluates. 
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this precipitation line and second peak. It is possible 
that antibodies to the secretory component may have been 
present but tn too small a concentration to show a pre-
cipitation line. 
Pooled elutions of second peak of human milk, 
containing free SC and lactoferrin concentrations were 
used as starting material for the chromatography. 
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Since there are small differences in elution volume 
between free SC and lactoferrin, it was difficult to sepa-
rate these components sufficiently by chromatography on 
Sephadex G-200. This was also true for the eluates that 
were subjected to the CM-50 cationic exchange column. Only 
very small concentrations of protein were obtained. 
Method Two 
The first fraction of prepared colostral whey eluted 
from O.OlM sodium phosphate buffer; pH 7.6 from the DEAE 
cellulose column contained the majority of SC. The second 
fraction eluted from 0.1M sodium phosphate, pH 6.4, yielded 
small quantities of S-IgA. The third fraction eluted from 
O.3M sodium phosphate, pH 4.8, eluted small amounts of 
lactoferrin. 
The first fraction was further fractionated by the 
addition of ammonium sulfate to make a 50% saturated solu-
tion (17). After discarding the precipitate obtained 
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through centrifugation at 30,000 Xg for 30 minutes, the 
supernatant was dialyzed against 0.005M sodium acetate 
buffer, pH 5.0, and applied on a eM-50 cellulose column 
against the same buffer. A linear gradient elution 
between 0.005M and 0.05M sodium acetate buffer, pH 5.0 was 
used. However, no fractions of protein were collected, 
possibly due to the small concentrations initially used to 
begin the linear gradient. 
DISCUSSION AND RECOMMENDATIONS 
This project was the beginning of a long-term study 
dealing with the local immune response of the S-IgA mole-
cule and SC against urinary tract infections. The 
purpose was to isolate SO from S-IgA in order to produce a 
monospecific antisera for this glyooprotein. Contamina-
tion with lactoferrin presented difficulties with the 
isolation of the SC, and the low immunogenicity of bound SO 
hampered the production of good antisera to this immuno-
globulin component. 
Several attempts have been made to release SC from 
S-IgA in order to make a specific antisera for both the SO 
and S-IgA, but have not provided conclusive information 
about the degradation process (1,3,4,5,6,18,13). 
In the studies by Munster (1) and Brandzaeg (19) an 
attempt was made to provide pertinent and important infor-
mation regarding the degradation process. 
Munster reported the antigenic differences between 
free SO and IgA bound SC to be the result of differences 
in quarternary structure between the tetrameric free form 
and the IgA-bound form. Brandzaeg went even further and 
described the forces stabilizing the quarternary structure 
of human S-IgA and established conditions for maximum 
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release of SC with intact antigenicity. 
Brandzaeg reported that there is at least one anti-
genic determinant of free SC which is inaccessible in the 
bound form and, therefore, may not elicit an antibody 
response (19). This is termed the I determinant and is 
apparently the most immunogenic part of the SC molecule 
(19) • 
The antigenicity of the accessible part of bound SC 
does not depend on a single determinant (20). In addition 
to a specific configurational characteristic, bound SC was 
found to have two antigenic gl'OUpS in common with the free 
component (AI and A2). The conventional antisera, the 
type I used, whereby reactions are exhibited to secretory 
components other than SC, for example lactoferrin, show 
better activity to Al than A2- Since there is better 
activity to Al it is possible that A2 is partly masked in 
the bound SC, and it may be visualized as the central 
region of the molecule (20). 
This inaccessible (I) determinant, as well as one 
of its accessible (AI) antigenic groups, is extremely 
susceptible to reduction and alkylation. Brandzaeg 
obtained secretory component free of lactoferrin from 
purified colostral IgA after reduction with O.lM B 
mercaptoethanol followed by alklation (20). 
Failure to obtain spurring between anti S-IgA and 
13 
second peak eluates could be a result of the conformational 
characteristics of SC free and bound to IgA. Brandzaeg
'
s 
method of reduction and alklation of colostral IgA could 
be one method to explore. 
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